Amy Limbacher

High-Dose-Rate Brachytherapy as Monotherapy Delivered in Two Fractions Within One Day for Favorable/Intermediate-Risk Prostate Cancer: Preliminary Toxicity Data

Michel Ghilezan, Alvaro A. Martinez, Gary Gustason et al. · International Journal of Radiation Oncology*Biology*Physics · 2011 · 91 citations

Urology, Radiation Therapy, Favorable/intermediate-risk Prostate Cancer +7

Five-Year Outcomes of a Single-Institution Prospective Trial of 19-Gy Single-Fraction High-Dose-Rate Brachytherapy for Low- and Intermediate-Risk Prostate Cancer

Z.A. Siddiqui, Gary Gustafson, Hong Ye et al. · International Journal of Radiation Oncology*Biology*Physics · 2019 · 63 citations

Single-institution Prospective Trial, Urology, Five-year Outcomes +6

Favorable Preliminary Outcomes for Men With Low- and Intermediate-risk Prostate Cancer Treated With 19-Gy Single-fraction High-dose-rate Brachytherapy

Daniel Krauss, Hong Ye, Alvaro A. Martinez et al. · International Journal of Radiation Oncology*Biology*Physics · 2016 · 59 citations

Surgical Oncology, Urology, Genitourinary Cancer +5

Rates of rectal toxicity in patients treated with high dose rate brachytherapy as monotherapy compared to dose-escalated external beam radiation therapy for localized prostate cancer

Jacob S. Parzen, Hong Ye, Gary Gustafson et al. · Radiotherapy and Oncology · 2020 · 12 citations

Radiation Therapy, Medicine, Localized Prostate Cancer +8

Increasing Fractional Doses Increases the Probability of Benign PSA Bounce in Patients Undergoing Definitive HDR Brachytherapy for Prostate Cancer

C.R. Hauck, Hong Ye, Peter Y. Chen et al. · International Journal of Radiation Oncology*Biology*Physics · 2017 · 10 citations

Urology, Medicine, Brachytherapy +5